RIM
IMDZ

RS Investment Management’s Immune Design Corp. IMDZ Stock Holding History

RS Investment Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$10M Buy
1,227,595
+38,123
+3% +$475K 0.1% 237
2016
Q1 		$15.5M Buy
1,189,472
+80,896
+7% +$934K 0.15% 205
2015
Q4 		$22.3M Buy
1,108,576
+122,910
+12% +$2.12M 0.2% 169
2015
Q3 		$12M Buy
985,666
+235,264
+31% +$4.41M 0.11% 223
2015
Q2 		$15.5M Buy
750,402
+227,530
+44% +$5.38M 0.13% 215
2015
Q1 		$11M Buy
522,872
+223,770
+75% +$5.84M 0.1% 235
2014
Q4 		$9.21M Buy
+299,102
New +$8.31M 0.08% 246

Other funds holding IMDZ

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RS Investment Management's IMDZ Position: Q2 2016 in Review

RS Investment Management increased its Immune Design Corp. (IMDZ) stake by 3.2% in Q2 2016, buying an estimated $475K and bringing the position to 1,227,595 shares worth $10M. The position accounts for 0.1% of the portfolio, ranked #237.

RS Investment Management first reported a position in IMDZ in Q4 2014 and has held it in 7 quarters since. The position peaked at $22.3M in Q4 2015. 60 funds tracked by Wall St. Rank hold IMDZ as of Q2 2016.

  • RS Investment Management held 1,227,595 shares of Immune Design Corp. worth $10M as of Q2 2016.
  • RS Investment Management bought 38,123 Immune Design Corp. shares in Q2 2016, an estimated $475K.
  • Immune Design Corp. made up 0.1% of RS Investment Management's portfolio in Q2 2016, its #237 holding.
  • RS Investment Management first reported a position in Immune Design Corp. in Q4 2014 and has held it in 7 quarters since.
  • RS Investment Management's Immune Design Corp. position peaked at $22.3M in Q4 2015.
  • 60 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.